
Prognostic Impact of Statin Intensity in Heart Failure Patients With Ischemic Heart Disease: A Report From the CHART‐2 (Chronic Heart Failure Registry and Analysis in the Tohoku District 2) Study
Author(s) -
Oikawa Takuya,
Sakata Yasuhiko,
Nochioka Kotaro,
Miura Masanobu,
Tsuji Kanako,
Onose Takeo,
Abe Ruri,
Kasahara Shintaro,
Sato Masayuki,
Shiroto Takashi,
Takahashi Jun,
Miyata Satoshi,
Shimokawa Hiroaki
Publication year - 2018
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.117.007524
Subject(s) - medicine , heart failure , hazard ratio , statin , cardiology , incidence (geometry) , proportional hazards model , clinical endpoint , prospective cohort study , observational study , propensity score matching , cohort , cohort study , clinical trial , confidence interval , physics , optics
The beneficial prognostic impact of statins has been established in patients with ischemic heart disease but not in those with heart failure (HF). In addition, it is still unclear whether patients benefit from statins regardless of low-density lipoprotein cholesterol levels.